<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recently, the incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has been increasing, associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We have found that type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> model KK-A(y) mice develop <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> within a short period by azoxymethane (AOM) treatment </plain></SENT>
<SENT sid="2" pm="."><plain>However, factors that contribute to the promotion of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> have not been clarified </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we looked at the genetic background of KK-A(y) , including two genetic characteristics of KK mice and C57BL/6J-Ham-A(y) /+ (A(y) ) mice, compared with other non-<z:mp ids='MP_0001261'>obese</z:mp> and non-diabetic mouse strains C57BL/6J and ICR, and induced colorectal <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e>, <z:mpath ids='MPATH_557'>aberrant crypt foci</z:mpath> (ACF), and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> using AOM (150 μg/mouse/week for 4 weeks and 200•μg/mouse/week for 6 weeks, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>The mice with a <z:mp ids='MP_0002055'>diabetes</z:mp> feature, KK-A(y) and KK, developed significantly more ACF, 67 and 61 per mouse, respectively, while ICR, A(y) and C57BL/6J developed 42, 24 and 18 ACF/mouse, respectively at 17 weeks of age </plain></SENT>
<SENT sid="5" pm="."><plain>Serum insulin and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels in KK-A(y) and KK mice were quite high compared with other non-diabetic mouse strains </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, KK-A(y) mice favor developing <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> (2.7 ± 2.3 tumor/mouse) over KK mice (1.2 ± 1.1 tumor/mouse) at 25 weeks of age, in spite of similar diabetic conditions </plain></SENT>
<SENT sid="7" pm="."><plain>Both <z:hpo ids='HP_0003003'>colon cancers</z:hpo> that developed both in KK-A(y) and KK mice showed similar activation of β-catenin signaling </plain></SENT>
<SENT sid="8" pm="."><plain>However, <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of inflammatory factors related to the activation of macrophages were significantly higher in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> of KK-A(y) than in KK </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate that factors such as <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> observed in the <z:mp ids='MP_0001261'>obese</z:mp> and diabetics could be involved in the susceptibility of colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, increase of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated macrophages may play important roles in the stages of promotion of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>